The present study aims to evaluate the antihypertensive effect of sacubitril/valsartan in
patients with resistant hypertension compared to the use of recommended and optimized
antihypertensive therapy, through a randomized clinical trial, over 12 weeks.
Phase:
Phase 2
Details
Lead Sponsor:
Hospital Geral Roberto Santos
Collaborator:
Hospital Universitário Professor Edgard Santos
Treatments:
LCZ 696 Sacubitril and valsartan sodium hydrate drug combination Valsartan